<DOC>
	<DOCNO>NCT01929499</DOCNO>
	<brief_summary>It report immune status patient cancer suppress , especially surgery adjuvant chemotherapy . Thus , immunotherapy may decrease recurrence rate surgery . CIK cell transfusion report effect therapy advance cancer . In another retrospective study , investigator find adjuvant CIK therapy would prolong disease-free survival ( DFS ) colorectal cancer patient . The purpose study determine wether adjuvant immunotherapy CIK cell patient colon cancer operation prolong DFS , overall survival ( OS ) .</brief_summary>
	<brief_title>Efficacy Adjuvant Cytokine-induced Killer Cells Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Colon cancer stage III stage II high risk R0 resection Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ; Life expectancy least 3 month ; Normal bone marrow , liver , renal , heart lung function ; Age 1880 ; Patients provide write informed consent study With uncontrolled malignant tumor ; With uncontrolled infection tubercle bacillus ( TB ) underlie disease severe life threatening ; Patients need treat radiotherapy ; Patients accept immunotherapy With sever mental disease disease central nervous system ( CNS ) ; With history organ transplantation , include bone marrow transplantation stem cell transplantation ; Patients auto immune disease ; pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Colon cancer</keyword>
	<keyword>Cytokine-induced killer cell</keyword>
	<keyword>Adjuvant immunotherapy</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
</DOC>